Spasticity
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis Cannabinoids in the management of spasticity associated with multiple sclerosis Clinical experiences with cannabinoids in spasticity management in multiple sclerosis Efficacy, safety, and tolerability of an orally administered cannabis extract in the treatment of […]